Observational studyScientific reports2026

Central and peripheral glutamatergic biomarkers delineate heterogeneous clinical phenotypes in olanzapine-treated schizophrenia.

Wirginia Krzyściak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.